Aarkstore - Fibrinogen Deficiency (Factor I Deficiency) - Pipeline Review, H2 2014

Submitted by: Submitted by

Views: 15

Words: 1148

Pages: 5

Category: Science and Technology

Date Submitted: 04/21/2015 11:24 PM

Report This Essay

Aarkstore - Fibrinogen Deficiency (Factor I Deficiency) - Pipeline Review, H2 2014

Browse Full Report @

http://www.aarkstore.com/pharmaceuticals-healthcare/100702/fibrinogen-deficiency-factor-i-deficiency-pipeline-review-h2-2014

Published: Sep 2014 | 32 Pages

PDF : $ 2000 | Site Licence: $ 4000 | Enterprise Wide Licence : $  6000

Summary

“Fibrinogen Deficiency (Factor I Deficiency) - Pipeline Review, H2 2014”, provides an overview of the Fibrinogen Deficiency (Factor I Deficiency)s therapeutic pipeline.

This Market Research Report provides comprehensive information on the therapeutic development for Fibrinogen Deficiency (Factor I Deficiency), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Fibrinogen Deficiency (Factor I Deficiency) and special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and...